[Adjuvant treatment of breast carcinoma].
Bruning
P F
PF
Afd. Inwendige Geneeskunde, Het Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis, Amsterdam.
Bartelink
H
H
van Dongen
J A
JA
Peterse
J L
JL
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010052:Ovariectomy; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use
D013629:Tamoxifen; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate
Adjuvante behandeling van mammacarcinoom.